Monday, 23 November 2015

Dec 4 - RIOH Directorship Presentation

Candidate: Dr Stephen Pistorius
Title: Improving Outcomes, through Research, for Manitobans with Cancer and Blood Disorders
Date: Tuesday 4 December 2015
Time: 12noon – 100pm
Location: Basic Medical Science Building - Theater B

Wednesday, 18 November 2015

Dec 14 - Cell Biology Club

Presenter 1: Laura Thompson (McManus Lab)
Presenter 2: Yingfeng Zheng (Murphy Lab)

Time : 2:00 - 3:00
Location: CCMB Lecture Theatre

Nov 30 - Cell Biology Club

Presenter: Ahmed Ali (Gibson/Marshall lab)
Time: 1:00 - 2:00
Location: CCMB Lecture Theatre


Nov 30 - Research Seminar by Dr David Eisenstat

Presenter: Dr David Eisenstat
Professor and Co-Director
Cancer Research Institute of Northern Alberta
Departments of Pediatrics, Medical Genetics and Oncology, University of Alberta


Date: Nov 30th 
Time: 2:00 - 3:00
Location: CCMB Lecture Theatre
Title: " Linking organ system development to cancer: role of the DLX homeobox genes". 

Tuesday, 3 November 2015

November 16 - Cell Biology Club

Presenter #1 - Sumanta Chaterjee (Raouf lab)
Presenter #2 - Pratima Basak (Mowat/Raouf labs)

Time: 2:00 - 3:00
Location: CCMB Lecture Theatre

November 12 - RIOH Director Presentation

Presenter: Dr Spencer Gibson
Title: "Building RIOH; a strategic plan to enhance research of cancer and blood disorders in Manitoba"
Time: 11:00 - 12:00
Location: CCMB Lecture Theatre

Open to all CCMB and University of Manitoba staff.

Friday, 23 October 2015

Oct 26 - SOMALogic Platform presentation

SomaLogic Platform New system for protein biomarker discovery and validation
Dr John Wilkins - Manitoba Centre for Proteomics & Systems Biology

2:00 – 3:00 
CCMB Lecture Theatre
SOMAscan employs Somamers (Slow Off-rate Modified aptamers) in a pool for simultaneous relative quantitation of 1310 protein analytes from a single 65μL sample. SomaLogic is useful for sequential analysis of patient derived materials including plasma, serum, cell and tissue lysates and supernatants. Potential assay applications include biomarker identification, predicting response to therapy, interrogation of basic biological processes in vitro and vivo.